The moment Athenex executives and investors have been waiting for is almost here


Results from the Phase 3 study of Athenex's leading drug candidate will be published in the middle of this year, potentially signaling to the world the arrival of its technology.

Previous Peninsula exec in college admissions scandal steps 'aside'
Next Cincinnati hospital moving operations to Dayton